102 related articles for article (PubMed ID: 2109455)
1. Alpha interferon dose-dependent suppression of secondary clones in a patient with Philadelphia-positive chronic myelogenous leukemia.
Claxton D; Kantarjian H; Kurzrock R; Trujillo JM; Gutterman JU; Talpaz M
Acta Haematol; 1990; 83(3):149-51. PubMed ID: 2109455
[TBL] [Abstract][Full Text] [Related]
2. Treatment of advanced stages of Philadelphia chromosome-positive chronic myelogenous leukemia with interferon-alpha and low-dose cytarabine.
Kantarjian HM; Keating MJ; Estey EH; O'Brien S; Pierce S; Beran M; Koller C; Feldman E; Talpaz M
J Clin Oncol; 1992 May; 10(5):772-8. PubMed ID: 1569449
[TBL] [Abstract][Full Text] [Related]
3. Use of quantitative polymerase chain reaction to monitor residual disease in chronic myelogenous leukemia during treatment with interferon.
Lion T; Gaiger A; Henn T; Hörth E; Haas OA; Geissler K; Gadner H
Leukemia; 1995 Aug; 9(8):1353-60. PubMed ID: 7643624
[TBL] [Abstract][Full Text] [Related]
4. Interferon alpha treatment of accelerated-phase chronic myeloid leukemia in relapse after bone marrow transplantation: a case with complete cytogenetic and molecular remission.
Steegmann JL; Pérez M; Vázquez L; Perez G; López J; Lamana M; Ferro MT; Resino M; González-Sarmiento R; Sánchez I
Bone Marrow Transplant; 1991 Jan; 7(1):65-7. PubMed ID: 2043879
[TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic myelogenous leukemia with interferons alpha and gamma.
Kloke O; May D; Wandl U; Becher R; Opalka B; Beer U; Niederle N
Blut; 1990 Jul; 61(1):45-6. PubMed ID: 2117476
[TBL] [Abstract][Full Text] [Related]
6. Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Philadelphia chromosome-positive patients.
Talpaz M; Kantarjian H; Kurzrock R; Trujillo JM; Gutterman JU
Ann Intern Med; 1991 Apr; 114(7):532-8. PubMed ID: 2001086
[TBL] [Abstract][Full Text] [Related]
7. Interferon-alpha plus low-dose cytosine arabinoside in advanced phase chronic myelogenous leukaemia patients.
Ferrajoli A; Liberati AM; Caricchi P; Donti E; Morra E; Lazzarino M; Betti AR; Bernasconi P; Saglio G
Eur J Haematol; 1995 Sep; 55(3):184-8. PubMed ID: 7672091
[TBL] [Abstract][Full Text] [Related]
8. [Clonal evolution of abnormal Philadelphia chromosome-negative cells after imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia].
Jiang Q; Chen SS; Jiang B; Jiang H; Lu Y; Qiu JY; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):23-6. PubMed ID: 15946504
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha: a Cancer and Leukemia Group B study.
Farag SS; Ruppert AS; Mrózek K; Carroll AJ; Pettenati MJ; Le Beau MM; Peterson BL; Powell BL; Ozer H; Silver RT; Larson RA; Bloomfield CD;
Int J Oncol; 2004 Jul; 25(1):143-51. PubMed ID: 15201999
[TBL] [Abstract][Full Text] [Related]
10. Additional translocation (9;12)(p13;q24.1) in newly diagnosed chronic myeloid leukemia: complete cytogenetic remission after interferon therapy.
Tertian G; Avalos MR; Léonard C; Lavergne JM; Misrahi M; Tchernia G
Hematol Cell Ther; 1996 Jul; 38(3):269-73. PubMed ID: 8974791
[TBL] [Abstract][Full Text] [Related]
11. Alpha interferon: perspectives in the biotherapy of chronic myelogenous leukemia.
Terebelo HR
Oncol Nurs Forum; 1991; 18(1 Suppl):5-9. PubMed ID: 1997975
[TBL] [Abstract][Full Text] [Related]
12. Improving the cytogenetic response to interferon alpha by zidovudine (AZT) in an HIV-positive chronic myelogenous leukemia patient.
Mahon FX; Nabera CB; Pellegrin JL; Cony-Makhoul P; Leng B; Bernard P; Reiffers J
Leuk Lymphoma; 1997 Jun; 26(1-2):205-7. PubMed ID: 9250808
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of cytogenetic response in Ph+ chronic myeloid leukemia patients treated with interferon alpha].
Hong H; Qiu JY; Lai YY; Shi Y; He Q; Dang H; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):269-73. PubMed ID: 12844411
[TBL] [Abstract][Full Text] [Related]
14. Effect of interferon-alpha in patients with chronic myelogenous leukemia in the accelerated phase: cytogenetic and molecular studies.
Ogura H; Tani K; Kozai Y; Watari K; Kodo H; Ozawa K; Asano S; Takaku F
Jpn J Cancer Res; 1990; 81(6-7):682-6. PubMed ID: 1976121
[TBL] [Abstract][Full Text] [Related]
15. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
Steinberg M
Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
[TBL] [Abstract][Full Text] [Related]
16. Suppression of cytogenetic clonal evolution with interferon alfa therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia.
Cortes J; Talpaz M; O'Brien S; Rios MB; Majlis A; Keating M; Freireich EJ; Kantarjian H
J Clin Oncol; 1998 Oct; 16(10):3279-85. PubMed ID: 9779702
[TBL] [Abstract][Full Text] [Related]
17. Therapy of chronic myelogenous leukemia.
Talpaz M; Kantarjian H; McCredie K; Trujillo J; Keating M; Gutterman JU
Cancer; 1987 Feb; 59(3 Suppl):664-7. PubMed ID: 10822467
[TBL] [Abstract][Full Text] [Related]
18. Chronic myelogenous leukemia: update on biology and treatment.
Faderl S; Kantarjian HM; Talpaz M
Oncology (Williston Park); 1999 Feb; 13(2):169-80; discussion 181, 184. PubMed ID: 10079468
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Philadelphia chromosome-positive early chronic phase chronic myelogenous leukemia with daily doses of interferon alpha and low-dose cytarabine.
Kantarjian HM; O'Brien S; Smith TL; Rios MB; Cortes J; Beran M; Koller C; Giles FJ; Andreeff M; Kornblau S; Giralt S; Keating MJ; Talpaz M
J Clin Oncol; 1999 Jan; 17(1):284-92. PubMed ID: 10458244
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate.
O'Dwyer ME; Gatter KM; Loriaux M; Druker BJ; Olson SB; Magenis RE; Lawce H; Mauro MJ; Maziarz RT; Braziel RM
Leukemia; 2003 Mar; 17(3):481-7. PubMed ID: 12646934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
